CClinicalTrials.gg
CompletedNCT06062784Updated Sep 3, 2025

Bedside Tests of Cardiorespiratory Fitness

An observational study in Aging, sponsored by University of Nottingham. Completed at 1 site in United Kingdom. Open to participants aged 65 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-09-03.

Sponsored by University of Nottingham · Observational

Study type
Observational
Model
Other
Time perspective
Other
Enrollment
64
Ages
65 Years and older
Sex
All
01

Study summary

A study of 64 older adults over the age of 65y to assess the utility of patient characteristics and bedside measures of physical function and muscle size to predict cardiorespiratory fitness.

Read the detailed description

A study of 64 older adults over the age of 65y to assess the utility of patient characteristics (age, gender and BMI) and bedside measures of physical function (handgrip strength (HGS) and step box test) and muscle size (muscle thickness via B-mode ultrasonography (US)) to predict cardiorespiratory fitness (VO2peak and anaerobic threshold) as measured by the gold-standard assessment method, cardiopulmonary exercise testing (CPET).

Each participant will take part in a single assessment day (after health screening against CPET safety criteria) whereby they will have US measures of the vastus lateralis before completing HGS and step box test assessments, and finally a CPET.

02

Conditions studied

  • Aging
03

In context

Lead sponsor

University of Nottingham is the lead sponsor of 455 studies on the registry; 77 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Community dwelling adults over the age of 65y who were able to provide written, informed consent and had no contraindications to exercise testing.

Inclusion criteria

  • Over 65y
  • Independent, community-dwelling

Exclusion criteria

Exclusion Criteria:

  • Contraindications to CPET safety criteria
05

Study design

Observational model
Other
Time perspective
Other
Enrollment
64 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Cardiorespiratory fitness (CRF) - VO2 max

    CRF via cardiopulmonary exercise testing (CPET). This includes a measure of maximum oxygen uptake (VO2 max) determined via inline breath gas analysis during an incremental cycle test.

    Time frame: Single time-point - 8 to 12 minutes

  2. Cardiorespiratory fitness (CRF) - Anaerobic threshold

    CRF via cardiopulmonary exercise testing (CPET). This includes a measure of anaerobic threshold (AT) determined via inline breath gas analysis during an incremental cycle test.

    Time frame: Single time-point - 8 to 12 minutes

Secondary outcomes

  1. Muscle architecture - muscle thickness

    Analysis of vastus lateralis muscle thickness using b-mode ultrasonography

    Time frame: Single time-point: 10 minutes

  2. Muscle architecture - pennation angle

    Analysis of vastus lateralis pennation angle using b-mode ultrasonography

    Time frame: Single time-point: 10 minutes

  3. Muscle architecture - fascicle length

    Analysis of vastus lateralis fascicle length using b-mode ultrasonography

    Time frame: Single time-point: 10 minutes

07

Study locations

1 site
  • Centre of Metabolism, Ageing and Physiology (COMAP), University of Nottingham
    Derby, Derbyshire DE22 3DT, United Kingdom
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 3, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06062784
Lead sponsor
University of Nottingham
Responsible party
Sponsor
First posted
Oct 2, 2023
Start date
Jan 1, 2019
Primary completion
Dec 31, 2021
Completion
Dec 31, 2021
Last update
Sep 3, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion